ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 141 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2016. The put-call ratio across all filers is 0.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $507,000 | -70.4% | 318,833 | -31.4% | 0.02% | -64.5% |
| Q3 2018 | $1,710,000 | -1.9% | 464,761 | -24.6% | 0.06% | -6.1% |
| Q2 2018 | $1,743,000 | -23.7% | 616,000 | 0.0% | 0.07% | -25.8% |
| Q1 2018 | $2,285,000 | +28.8% | 616,000 | 0.0% | 0.09% | +30.9% |
| Q4 2017 | $1,774,000 | -35.9% | 616,000 | 0.0% | 0.07% | -31.3% |
| Q3 2017 | $2,766,000 | +50.9% | 616,000 | +38.8% | 0.10% | +26.9% |
| Q4 2016 | $1,833,000 | -51.5% | 443,851 | -18.9% | 0.08% | -42.6% |
| Q3 2015 | $3,782,000 | -22.0% | 547,300 | 0.0% | 0.14% | -22.3% |
| Q2 2015 | $4,849,000 | -55.1% | 547,300 | -50.0% | 0.18% | -59.1% |
| Q1 2015 | $10,792,000 | – | 1,094,600 | – | 0.43% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |